SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8610733
Source:
http://linkedlifedata.com/resource/pubmed/id/8610733
Search
Subject
Predicate
Object
All
(
58
)
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists.
Subject
Predicate
Object
Context
pubmed-article:8610733
rdf:type
pubmed:Citation
lld:pubmed
pubmed-article:8610733
lifeskim:mentions
umls-concept:C0030705
lld:lifeskim
pubmed-article:8610733
lifeskim:mentions
umls-concept:C0001779
lld:lifeskim
pubmed-article:8610733
lifeskim:mentions
umls-concept:C0087111
lld:lifeskim
pubmed-article:8610733
lifeskim:mentions
umls-concept:C0023473
lld:lifeskim
pubmed-article:8610733
lifeskim:mentions
umls-concept:C0002199
lld:lifeskim
pubmed-article:8610733
lifeskim:mentions
umls-concept:C1274040
lld:lifeskim
pubmed-article:8610733
lifeskim:mentions
umls-concept:C0439234
lld:lifeskim
pubmed-article:8610733
pubmed:issue
4
lld:pubmed
pubmed-article:8610733
pubmed:dateCreated
1996-5-30
lld:pubmed
pubmed-article:8610733
pubmed:abstractText
To determine the response rate to interferon-alpha (IFN-alpha) in patients with chronic myelogenous leukemia (CML) aged 60 years and older.
lld:pubmed
pubmed-article:8610733
pubmed:language
eng
lld:pubmed
pubmed-article:8610733
pubmed:journal
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:8610733
pubmed:citationSubset
AIM
lld:pubmed
pubmed-article:8610733
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:8610733
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:8610733
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:8610733
pubmed:chemical
http://linkedlifedata.com/r...
lld:pubmed
pubmed-article:8610733
pubmed:status
MEDLINE
lld:pubmed
pubmed-article:8610733
pubmed:month
Apr
lld:pubmed
pubmed-article:8610733
pubmed:issn
0002-9343
lld:pubmed
pubmed-article:8610733
pubmed:author
pubmed-author:PierceSS
lld:pubmed
pubmed-article:8610733
pubmed:author
pubmed-author:O'BrienSS
lld:pubmed
pubmed-article:8610733
pubmed:author
pubmed-author:TalpazMM
lld:pubmed
pubmed-article:8610733
pubmed:author
pubmed-author:CortesJJ
lld:pubmed
pubmed-article:8610733
pubmed:author
pubmed-author:RobertsonL...
lld:pubmed
pubmed-article:8610733
pubmed:author
pubmed-author:KantarjianHH
lld:pubmed
pubmed-article:8610733
pubmed:issnType
Print
lld:pubmed
pubmed-article:8610733
pubmed:volume
100
lld:pubmed
pubmed-article:8610733
pubmed:owner
NLM
lld:pubmed
pubmed-article:8610733
pubmed:authorsComplete
Y
lld:pubmed
pubmed-article:8610733
pubmed:pagination
452-5
lld:pubmed
pubmed-article:8610733
pubmed:dateRevised
2008-11-21
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:meshHeading
pubmed-meshheading:8610733-...
lld:pubmed
pubmed-article:8610733
pubmed:year
1996
lld:pubmed
pubmed-article:8610733
pubmed:articleTitle
Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.
lld:pubmed
pubmed-article:8610733
pubmed:affiliation
Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
lld:pubmed
pubmed-article:8610733
pubmed:publicationType
Journal Article
lld:pubmed
pubmed-article:8610733
pubmed:publicationType
Clinical Trial
lld:pubmed
pubmed-article:8610733
pubmed:publicationType
Comparative Study
lld:pubmed
pubmed-article:8610733
pubmed:publicationType
Controlled Clinical Trial
lld:pubmed